Andere Kunden interessierten sich auch für
![Ossification of Axis]( "Ossification of Axis")
Ossification of Axis19,99 €![National Transport Commission]( "National Transport Commission")
National Transport Commission25,99 €![Spontaneous Conception]( "Spontaneous Conception")
Spontaneous Conception22,99 €![National Survey of Sexual Health and Behavior]( "National Survey of Sexual Health and Behavior")
National Survey of Sexual Health and Behavior22,99 €![Spinal Adjustment]( "Spinal Adjustment")
Spinal Adjustment22,99 €![Teeth Cleaning]( "Teeth Cleaning")
Teeth Cleaning22,99 €![Angiozentrisches Gliom]( "Angiozentrisches Gliom")
Angiozentrisches Gliom29,00 €
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Semapimod (INN), formerly known as CNI-1493, is an investigational new drug which has anti-inflammatory, anti-cytokine, immunomodulatory, antiviral and antimalarial properties.Semapimod was developed at the former Picower Institute for Medical Research, and is now licensed to Cytokine PharmaSciences. In 2000, Cytokine PharmaSciences licensed anti-infective applications of semapimod to Axxima Pharmaceuticals, but Axxima became insolvent in Dec. 2004 and its assets were acquired by GPC Biotech, which has recently merged into Agennix AG. Although the disposition of Axxima's partial rights to semapimod was not specified in these merger announcements, Cytokine PharmaSciences does not currently list any licensees for semapimod on its website.